Embecta now expects revenues between $1.073 billion and $1.09 billion. This would mark a sales dip of between 4.4% and 2.9% ...

Insulet recorded a 31.3% bottom-line slide on a sales increase of 28.8%. Adjusted to exclude one-time items, earnings per ...

(NYSE:SENS) shares dipped after hours today on first-quarter results that beat revenue projections on Wall Street.

A mission to outer space includes plans to utilize modern diabetes management technology to assess its viability in ...

Phillips Medisize announced that it officially integrated Vectura into its business, expanding its capabilities in inhaled ...

Beta Bionics (Nasdaq:BBNX) shares remained unmoved after hours today on first-quarter results that topped the consensus sales ...

Oura and Stelo alongside the mobile app. [Image courtesy of Dexcom/Oura] Dexcom (NASDAQ:DXCM) announced today that it expanded its partnership with Oura, officially launching an integration with Stelo ...